This HTML5 document contains 54 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1159/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q93077200
rdf:type
wikibase:Item
schema:description
2019 թվականի ապրիլի 12-ին հրատարակված գիտական հոդված artículu científicu espublizáu n'abril de 2019 наукова стаття, опублікована 12 квітня 2019 scientific article published on 12 April 2019 wetenschappelijk artikel
p:P577
wds:Q93077200-515334CB-9686-4BCD-B9A5-BCB0815DA141
wdt:P577
2019-04-12T00:00:00Z
p:P2093
wds:Q93077200-F4112F22-ADA8-49A1-8780-F7554D1EBF10 wds:Q93077200-73681CB6-9172-4C44-8DCA-3BB069879FA4 wds:Q93077200-8C6F1E15-F0C2-48D6-8E89-76C38E281BEB wds:Q93077200-58F71E5B-C0DB-44F0-BF1F-0DE510D1DA03 wds:Q93077200-C2B83B4D-6863-415B-82A6-490A7C12DBF4 wds:Q93077200-D2837495-1C1B-46DA-8D92-3E00C09A9165 wds:Q93077200-9B531D3F-79A5-4A0F-B9C7-4DA9C5F03A32 wds:Q93077200-F2910EFC-C78A-4714-A1AC-82000A0DF8D4 wds:Q93077200-E456AC33-1C01-4419-A11D-47B650B829B2 wds:Q93077200-E5D489F0-80BA-4584-9101-C9A1DD11DBE2
wdt:P2093
Laetitia Huriaux Kevin Chaulier Thibaut Girardot Julien Illinger Arnaud Grégoire Jullien Crozon-Clauzel Thomas Rimmelé Victor Schwindenhammer Thomas Uberti Céline Monard
rdfs:label
oXiris® Use in Septic Shock: Experience of Two French Centres oXiris® Use in Septic Shock: Experience of Two French Centres
skos:prefLabel
oXiris® Use in Septic Shock: Experience of Two French Centres oXiris® Use in Septic Shock: Experience of Two French Centres
schema:name
oXiris® Use in Septic Shock: Experience of Two French Centres oXiris® Use in Septic Shock: Experience of Two French Centres
p:P50
wds:Q93077200-52AF8B34-EB5D-427D-9F8B-DC03E03FAD8C
wdt:P50
wd:Q115032668
p:P1476
wds:Q93077200-096FB038-25FA-4816-94A0-4D3EF6BCCD66
wdt:P1476
oXiris® Use in Septic Shock: Experience of Two French Centres
p:P304
wds:Q93077200-EC6DD1EF-BCCC-484C-8E8D-D46D6D41360A
wdt:P304
1-7
p:P31
wds:Q93077200-B86A2D24-90B3-4C84-AB2E-EE9D7A0112C6
wdt:P31
wd:Q13442814
p:P921
wds:Q93077200-41441BCC-BCE9-4E95-B34B-EF855B65E3AE
wdt:P921
wd:Q1765564
p:P698
wds:Q93077200-33E0FE10-B774-44F5-9952-36557E50B84D
wdtn:P698
n9:30982028
wdt:P698
30982028
p:P1433
wds:Q93077200-12FC889F-A406-485A-AAA0-EEAACADC42E8
wdt:P1433
wd:Q15759923
p:P478
wds:Q93077200-32688E9F-2486-4081-BE10-76DEAB3B67BF
wdt:P478
47 Suppl 3
p:P356
wds:Q93077200-5CD54BE5-D85B-4F7B-A333-11F32DFC5FF2
wdtn:P356
n11:000499510
wdt:P356
10.1159/000499510